IPO filing research

Biophytis SA

Pharmaceutical Preparations

follow-on filed F-1

Biophytis SA IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: F-1 on 2023-08-04.

Filing Timeline

SEC EDGAR

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows F-1 in the pre-IPO sequence.

2024-04-08 · 0001104659-24-044790

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows 424B5 in the pre-IPO sequence.

2023-08-04 · 0001104659-23-087853

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2023-07-20 · 0001104659-23-082796

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 20-F and marks the registration effective.

2023-05-01 · 9999999995-23-001211

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows 20-F in the pre-IPO sequence.

2023-04-19 · 0001104659-23-046877

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows 20-F in the pre-IPO sequence.

2022-04-21 · 0001104659-22-048113

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows 424B4 in the pre-IPO sequence.

2021-03-12 · 0001104659-21-035487

424B4 priced

Final prospectus

Final prospectus filed after pricing with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2021-02-11 · 0001047469-21-000343

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows CERT and marks the registration effective.

2021-02-09 · 9999999995-21-000527

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows FWP in the pre-IPO sequence.

2021-02-08 · 0001354457-21-000184

FWP supplemental

Free writing prospectus

Prospectus supplement or marketing filing that often updates active offering terms.

Follows F-1/A and supplements the active offering with updated prospectus details.

2021-02-08 · 0001104659-21-013832

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior 8-A12B filing.

2021-02-08 · 0001047469-21-000313

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows F-1/A and registers the class of securities for exchange listing.

2021-02-04 · 0001104659-21-012221

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior FWP filing.

2021-02-04 · 0001047469-21-000285

FWP supplemental

Free writing prospectus

Prospectus supplement or marketing filing that often updates active offering terms.

Follows F-1/A and supplements the active offering with updated prospectus details.

2021-02-03 · 0001104659-21-011161

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior F-1 filing.

2021-02-02 · 0001047469-21-000248

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

2021-01-19 · 0001047469-21-000136

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2020-12-23 · 0001104659-20-139118

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after CERT.

2020-11-20 · 0001104659-20-127953

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows RW in the pre-IPO sequence.

2019-07-25 · 0001354457-19-000372

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

Follows F-1/A and ends the active registration process.

2019-07-24 · 0001104659-19-041610

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior CERT filing.

2019-07-16 · 0001047469-19-004202

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows F-1/A in the pre-IPO sequence.

2019-07-15 · 0001354457-19-000349

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior 8-A12B filing.

2019-07-15 · 0001047469-19-004186

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows F-1/A and registers the class of securities for exchange listing.

2019-07-12 · 0001104659-19-040106

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior FWP filing.

2019-07-11 · 0001047469-19-004124

FWP supplemental

Free writing prospectus

Prospectus supplement or marketing filing that often updates active offering terms.

Follows F-1/A and supplements the active offering with updated prospectus details.

2019-07-09 · 0001104659-19-039596

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior F-1/A filing.

2019-07-08 · 0001047469-19-004041

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior F-1/A filing.

2019-06-24 · 0001047469-19-003824

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior F-1 filing.

2019-06-12 · 0001047469-19-003597

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows DRS in the pre-IPO sequence.

2019-05-22 · 0001047469-19-003239

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

2019-02-25 · 0000912057-19-000063

Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 20 using nearest neighbors.

Showing top 8 by similarity.

+9.1%

Median day-1

60%

Above issue

+0.7%

Median week-1

-20.9%

Downside (p10)

BlossomHill Therapeutics, Inc. BLSM

2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%

same SICrecent IPO

Latigo Biotherapeutics, Inc. LTGO

2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%

same SICrecent IPO

Braveheart Bio, Inc. BRVE

2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%

same SICrecent IPO

Apnimed, Inc. APMD

2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%

same SICrecent IPO

Kardigan, Inc. KARD

2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%

same SICrecent IPO

Parabilis Medicines, Inc. PBLS

2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%

same SICrecent IPO

Seaport Therapeutics, Inc. SPTX

2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%

same SICrecent IPO

Avalyn Pharma Inc. AVLN

2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%

same SICrecent IPO

Recent News

No recent news stored for this issuer.